In Vivo Study of Femptosecond Laser Ablation
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2005 - February 28, 2007
Grant ID
G2005021
Summary
The current procedure for reducing eye pressure is to make an opening in the trabecular meshwork to allow the aqueous humor to flow more freely into the Schlemm’s canal. A common form of this procedure is known as laser trabecular ablation, or LTA. This procedure involves long pulse durations that can cause collateral damage, including inflammation and scarring, and eventually leads to closure of the incision. Dr. Edward plans to study the results of a new technique using an ultrafast Titanium Sapphire laser, which has been found to overcome all of the aforementioned problems. By studying changes in the treated eye over a period of up to two months, Dr. Edward hopes to better understand the interplay between mechanical effects of the laser and the biologic response that might occur during wound healing.
Related Grants
National Glaucoma Research
The Role of Microtubules in Glaucomatous Schlemm’s Canal Mechanobiology
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Haiyan Li, PhD
Current Organization
Georgia Institute of Technology
The Role of Microtubules in Glaucomatous Schlemm’s Canal Mechanobiology
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Haiyan Li, PhD
Current Organization
Georgia Institute of Technology
National Glaucoma Research
Pressure-Induced Axon Damage and Its Link to Glaucoma-Related Vision Loss
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Bingrui Wang, PhD
Current Organization
University of Pittsburgh
Pressure-Induced Axon Damage and Its Link to Glaucoma-Related Vision Loss
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Bingrui Wang, PhD
Current Organization
University of Pittsburgh
National Glaucoma Research
Why Certain Retina Ganglion Cells Stay Strong in Glaucoma
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Mengya Zhao, PhD
Current Organization
University of California, San Francisco
Why Certain Retina Ganglion Cells Stay Strong in Glaucoma
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Mengya Zhao, PhD
Current Organization
University of California, San Francisco